Literature DB >> 6489450

Effects of the calmodulin inhibitor, trifluoperazine, on membrane potentials and slow action potentials of cultured heart cells.

G Bkaily, N Sperelakis, M Eldefrawi.   

Abstract

The effects of an inhibitor of calmodulin, trifluoperazine (TFP), were determined on the electrical activity of cultured cell reaggregates derived from chick embryonic hearts (15-day-old). The cells exhibited naturally occurring slowly rising action potentials (APs) having a maximum rate of rise (+Vmax) of less than 35 V/s. After superfusion with 100 microM TFP, the maximal diastolic potential (MDP) decreased, within 30 min, from -66.0 to -55.5 mV. The frequency of discharge decreased, and there was also a decrease in AP amplitude and in +Vmax (from 10.0 to 4.9 V/s). By 90 min, all spontaneous activity had stopped, and the resting potential was about -10 mV. Input resistance increased, consistent with a decrease in K+ conductance. Hyperpolarization by current pulses did not allow the production of APs upon electrical stimulation, suggesting that the TFP blocks slow inward current (Isi). No recovery occurred upon washout (up to 48 h). Higher concentrations of TFP (200-500 microM), or injection of the inhibitor intracellularly be means of phosphatidylcholine liposomes, accelerated the time course of the blockade (e.g. within 15 min). In fresh (non-cultured) chick ventricle with fast-rising APs, TFP (400 microM) caused excitation-contraction uncoupling within 10 min, presumably by blocking the slow Ca2+ channels; the the fast APs were depressed (+Vmax) within 45 min, before any depolarization occurred. The cells became completely depolarized (Em congruent to -4 mV) by 195 min; hyperpolarization by current pulses did not allow the production of APs, suggesting that the fast Na+ channels were blocked.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6489450     DOI: 10.1016/0014-2999(84)90645-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

Review 1.  Regulation of ion channels in myocardial cells and protection of ischemic myocardium.

Authors:  N Sperelakis; M Sunagawa; H Yokoshiki; T Seki; M Nakamura
Journal:  Heart Fail Rev       Date:  2000-06       Impact factor: 4.214

Review 2.  Properties of calcium channels in cardiac muscle and vascular smooth muscle.

Authors:  N Sperelakis
Journal:  Mol Cell Biochem       Date:  1990-12-20       Impact factor: 3.396

3.  Regulation of Ca2+ influx in myocardial cells by beta adrenergic receptors, cyclic nucleotides, and phosphorylation.

Authors:  N Sperelakis; G M Wahler
Journal:  Mol Cell Biochem       Date:  1988 Jul-Aug       Impact factor: 3.396

Review 4.  Regulation of the slow Ca++ channels of myocardial cells.

Authors:  N Sperelakis; Y Katsube; H Yokoshiki; H Sada; K Sumii
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

5.  Blockade by calmodulin inhibitors of Ca2+ channels in smooth muscle from rat vas deferens.

Authors:  K Nakazawa; K Higo; K Abe; Y Tanaka; H Saito; N Matsuki
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

6.  Effect of antipsychotic drug perphenazine on fast sodium current and transient outward potassium current in rat ventricular myocytes.

Authors:  Markéta Bébarová; Peter Matejovic; Michal Pásek; Dagmar Jansová; Milena Simurdová; Marie Nováková; Jirí Simurda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-05-09       Impact factor: 3.000

7.  Effects of calcium, calcium entry blockers and calmodulin inhibitors on atrioventricular conduction disturbances induced by hypoxia.

Authors:  T Anno; I Kodama; S Shibata; J Toyama; K Yamada
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

8.  Inhibition of calmodulin and protein kinase C by amiodarone and other class III antiarrhythmic agents.

Authors:  P J Silver; M J Connell; K M Dillon; W R Cumiskey; W A Volberg; A M Ezrin
Journal:  Cardiovasc Drugs Ther       Date:  1989-10       Impact factor: 3.727

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.